首页> 外文期刊>Oncology letters >Clinical characteristics and treatment outcomes of parathyroid carcinoma: A retrospective review of 234 cases
【24h】

Clinical characteristics and treatment outcomes of parathyroid carcinoma: A retrospective review of 234 cases

机译:甲状旁腺癌的临床特征及治疗结果:回顾性综述234例

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Parathyroid carcinoma (PC) is one of the rarest known types of cancer and has a moderate prognosis, with estimated 5- and 10-year overall survival rates between 78-85% and between 49-70%, respectively. To raise awareness of this disease, and to optimize its diagnosis, clinical management and prognosis, the present study retrospectively reviewed 234 cases of PC. A total of 226 cases of PC, which were archived between 1984 and 2015 in the three major databases of the Chinese population, were retrieved and pooled with the 8 cases diagnosed and treated at the Department of Thyroid Surgery of The First Hospital of Jilin University (Changchun, China) between June 2008 and December 2015. The clinicopathological features, diagnosis, surgical procedures and outcomes of these cases of PC were investigated. The review revealed that misdiagnosis has been a considerable issue, with >80% of the patients misdiagnosed prior to surgery, and the accuracy of intraoperative diagnosis based on frozen sections was only 15.04%. The use of radical resection as first-line therapy significantly improved the disease-free survival by similar to 8 years (log-rank, 20.956; P<0.001); and, at re.001). Consistently, a Cox proportional hazards analysis indicated that radical resection as a first-line theraplapse, reoperation prolonged patient survival by similar to 7 years (log-rank, 35.322; P<0y reduced the risk of postoperative recurrence (P=0.030), and that reoperation following recurrence significantly improved patient survival (P=0.030). The 5-and 10-year cumulative disease-specific survival rates of the cases of PC were 83 and 67%, respectively. Notably, an increased mortality rate was observed among males with PC compared with female patients with PC. In summary, in the past 32 years (1984-2015), the majority of patients with PC have been misdiagnosed. Performing radical resection as the first-line therapy significantly reduces recurrence and improves patient survival time; and, following relapse, subsequent surgery has also been demonstrated to be an effective approach.
机译:甲状旁腺癌(PC)是最罕见的已知类型的癌症之一,预后具有中等的预后,估计分别为78-85%和49-70%的总生存率。为了提高对这种疾病的认识,并优化其诊断,临床管理和预后,本研究回顾性地审查了234例PC。在1984年至2015年期间,在中国人口的三个主要数据库中,共有226份PC存档,并汇总了吉林大学第一医院甲状腺术部诊断和治疗的8例2008年6月和2015年12月之间的长春和2015年12月。调查了这些PC病例的临床病理特征,诊断,外科手术和结果。审查显示,误诊已经是一个相当大的问题,> 80%的患者在手术前误诊,基于冷冻部分的术中诊断的准确性仅为15.04%。作为一线治疗的激进切除的使用显着提高了无疾病存活率,类似于8年(对数级,20.956; P <0.001);并且,在RE.001)。始终如一地,Cox比例危害分析表明,激进切除作为第一线Theraplapse,重新组合延长的患者存活率与7年相似(对数秩,35.322; P <0Y降低了术后复发的风险(P = 0.030),和复发后重新进入显着改善了患者存活率(p = 0.030)。PC病例的5和10年累积疾病特异性存活率分别为83和67%。值得注意的是,雄性中观察到增加的死亡率增加与PC相比,与PC患者相比。总之,在过去的32年(1984-2015)中,PC的大多数患者都被误诊。随着第一线疗法进行激进切除,显着降低了复发并改善了患者存活时间;随后复发后,随后的手术也被证明是一种有效的方法。

著录项

  • 来源
    《Oncology letters》 |2017年第3期|共7页
  • 作者单位

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ China Japan Union Hosp Dept Orthoped Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

    Jilin Univ Hosp 1 Dept Thyroid Surg 71 Xinmin St Changchun 130021 Jilin Peoples R China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    parathyroid carcinoma; thyroid cancer; endocrine cancer; radical resection;

    机译:甲状旁腺癌;甲状腺癌;内分泌癌;激进切除;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号